Venus Remedies has informed that it has received Marketing Authorizations for Paclitaxel 100m9/16.7rn1 and Zolendronic Acid 4mg in the Philippines, located in the dynamic region of Asia (South East). ln addition, the company has also secured Marketing Authorization for Bleomycin 1SlU from SaudiArabia. These regulatory approvals signify a significant milestone for Venus Remedies, reflecting the company's commitment to advancing healthcare solutions and expanding its global presence. The company is dedicated to delivering high-quality pharmaceuticals that contribute to improving patient outcomes and addressing critical medical needs. Press release of the same is enclosed.
The above information is a part of company’s filings submitted to BSE.
